SpringWorks - SWTX Quarterly EPS earnings growth

Corporate company logo of SpringWorks Therapeutics, Inc. (SWTX)

The development of targeted therapies for rare neoplasms and alliances with industry behemoths minimize risks for SpringWorks Therapeutics (SWTX). Quarterly EPS volatility demonstrates a growth peak, where 6.40 serves as the current parameter value. AI-driven automated molecule screening systems enhance efficiency, while operations within a secure US perimeter guarantee stability, eliminating the impact of foreign policy conflicts on the business.

springworkstx.com (SWTX) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 07/12/2025

Analytical breakdowns for SpringWorks Therapeutics

- share price and consensus valuation forecast:
Stock Quotes SpringWorks Therapeutics, Inc.|SWTX - Analyst Forecast Prices
- issuer market value details:
Market Capitalization SpringWorks|SWTX - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share SpringWorks Therapeutics|SWTX - Accounting Value of Company|Market Capitalization to Book Value Ratio springworkstx.com|SWTX - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Capital SpringWorks Therapeutics|SWTX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio SpringWorks Therapeutics|SWTX - Company Cumulative Indebtedness|Debts to Book Capitalization SpringWorks|SWTX - Long-Term Debt|Company Short-Term Debts SpringWorks Therapeutics|Quick Liquidity Indicator springworkstx.com
- earnings and market multiples details:
SWTX - Final Profit|Future Profit SpringWorks Therapeutics|SWTX - Market Price to Net Income Ratio|Forward P/E Multiple SpringWorks|SWTX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple SpringWorks|SWTX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months SpringWorks Therapeutics|SWTX - Earnings per share for the trailing year|Quarterly EPS earnings growth springworkstx.com|SWTX - Earnings growth in current year|Net earnings per share growth forecast for next year SpringWorks Therapeutics
Fundamental company valuation:SpringWorks Therapeutics, Inc. - SWTX
Flagship merchandise of springworkstx.com

SpringWorks Therapeutics (SWTX) minimizes capital expenditures by outsourcing production and testing to third-party contractors, ensuring a flexible cost structure. This trend is reflected in the quarterly change in earnings per share, which measures the growth rate of net income, allowing investors to assess the business's fundamental momentum and forecast profit regularity based on this chart.

Analysis of competing companies

GMAB (Genmab) - Year-over-year net earnings per share growth for the last 12 months|EXEL: Year-over-year earnings per share growth rate for the last twelve months|NUVL (Nuvalent Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Kymera Corp|Year-over-year earnings per share growth for the last twelve months IDEAYA Biosciences (IDYA)|ELVN (enliventherapeutics.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORIC (ORIC Pharmaceuticals, Inc.)|Net earnings per share growth for the trailing year Relay Therapeutics Inc|Nurix Pharma - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Tyra Corp|VSTM (Verastem, Inc.) - Year-over-year net earnings per share growth for the last 12 months|GLUE: Year-over-year earnings per share growth rate for the last twelve months|CGEM (Cullinan Therapeutics, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immuneering Corp IMRX|Quarterly EPS earnings growth CCCC|Black Diamond Therapeutics, Inc - Year-over-year earnings per share growth for the last 12 months|Repare Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PMVP|KPTI: Year-over-year net earnings per share growth for the last 12 months|Propanc Biopharma Inc - Year-over-year earnings per share growth rate for the last twelve months|BGMS: Quarterly EPS earnings growth|Aadi Bioscience, Inc. - Year-over-year earnings per one share growth for the last 12 months|ALRN (Aileron Therapeutics Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Blueprint Medicines Corp BPMC|Year-over-year earnings per share growth for the last twelve months GlycoMimetics, Inc. (GLYC)